The Role of Biomarkers in Preventing Cardiovascular Disease
Preventing cardiovascular disease is far more effective than treating it, and cardiac biomarkers are playing an increasingly important role in this proactive approach. Beyond their use in diagnosing acute events, these biomarkers can help identify individuals who are at high risk for heart disease long before they show any symptoms. For example, a high-sensitivity CRP test can detect low-grade inflammation, a silent but significant contributor to atherosclerosis. Similarly, elevated levels of certain lipids and other markers can signal a person's genetic predisposition to heart disease. By incorporating these tests into routine check-ups, doctors can create personalized prevention strategies that include diet, exercise, and medication. This ability to identify and mitigate risk early on is a new frontier in cardiology, and it's a key growth area for the Cardiac Biomarkers Market.